Ann: OncoSil Investor Update, page-24

That’s correct TT.

Also, I think Oncosil put in application for reimbursement along with the TGA application.

Another significant benefit of obtaining FDA approval for bile duct is that it allows the company reimbursement in the US.

Plus, with FDA approval the company will attract further interest from investors, probably institutions and funds that invest in FDA approved companies.

To suggest Dr Dopa that why haven’t there been sales in the UK. UK hospitals have been in lockdown and severe stress due to Covid. This should improve with the vaccine rollout. I believe the company stated that there will be sales in the first half of the year from London and perhaps also Manchester hospitals.